publication venue for
- Targeting cancer's sweet spot: UGP2 as a therapeutic vulnerability.. 8. 2021
- Histone H3 variants at the root of metastasis.. 7. 2020
- When fat goes down, prostate cancer is on the ropes.. 6. 2019
- PARK2 loss promotes cancer progression via redox-mediated inactivation of PTEN.. 4. 2017
- BAK regulates catalase release from peroxisomes.. 4. 2017
- PARK2 loss promotes cancer progression via redox-mediated inactivation of PTEN 2017
- PARK2 loss promotes cancer progression via redox-mediated inactivation of PTEN 2017
- Genomic profile, smoking, and response to anti-PD-1 therapy in non-small cell lung carcinoma.. 3. 2015
- Taspase 1: A protease with many biological surprises.. 2. 2015
- Untargeted metabolomics for profiling oncogene-specific metabolic signatures of prostate cancer.. 2. 2015
- Cutting the brakes on hematopoietic regeneration by blocking TGFβ to limit chemotherapy-induced myelosuppression. 2015
- Trial Watch: Proteasomal inhibitors for anticancer therapy. 2014
- Chloroquine and hydroxychloroquine for cancer therapy. 2014